{"protocolSection":{"identificationModule":{"nctId":"NCT04108169","orgStudyIdInfo":{"id":"20190926"},"organization":{"fullName":"Beijing Institute of Heart, Lung and Blood Vessel Diseases","class":"OTHER"},"briefTitle":"Association Between S-LAAO and Adverse Cardiovascular Events Among Patients Undergoing Coronary Artery Bypass Grafting.","officialTitle":"A Chinese Registry to Evaluate the Association of Surgical Left Atrial Appendage Occlusion vs No Receipt of S-LAAO With Adverse Cardiovascular Events Among Petients Undergoing Coronary Artery Bypass Grafting."},"statusModule":{"statusVerifiedDate":"2019-09","overallStatus":"UNKNOWN","lastKnownStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2019-10-01","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2022-10-01","type":"ESTIMATED"},"completionDateStruct":{"date":"2023-01","type":"ESTIMATED"},"studyFirstSubmitDate":"2019-09-26","studyFirstSubmitQcDate":"2019-09-27","studyFirstPostDateStruct":{"date":"2019-09-30","type":"ACTUAL"},"lastUpdateSubmitDate":"2019-09-27","lastUpdatePostDateStruct":{"date":"2019-09-30","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Beijing Institute of Heart, Lung and Blood Vessel Diseases","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This is a prospective, single-center, randomized, active controlled, clinical trail to assess the efficacy and safety of surgical closure of left atrial appendage (LAA) in patients undergoing coronary artery bypass graft."},"conditionsModule":{"conditions":["Heart Surgery"],"keywords":["Coronary artery bypass graft","Left Atrial Appendage Occlusion","stroke","prevention"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"DOUBLE","whoMasked":["INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":240,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Active Comparator","type":"ACTIVE_COMPARATOR","interventionNames":["Procedure: Left atrial appendage occlusion surgery"]},{"label":"Sham Comparator","type":"NO_INTERVENTION"}],"interventions":[{"type":"PROCEDURE","name":"Left atrial appendage occlusion surgery","description":"CABG according to indications in the current guidelines on myocardial revascularization including surgical closure of left atrial appendage","armGroupLabels":["Active Comparator"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"All-cause death","timeFrame":"3 year after discharge (These data is collected during follow-up visit at in-hospital)"}],"secondaryOutcomes":[{"measure":"Atrial fibrillation","timeFrame":"3 year after discharge (These data is collected during follow-up visit at in-hospital)"},{"measure":"Composite of ischemic stroke, thromboembolism and all death","timeFrame":"3 year after discharge (These data is collected during follow-up visit at in-hospital)"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Subject undergoing coronary artery bypass grafting according to clinical indications;\n2. Age is more than 18 and less than 80 years old;\n3. Male and non pregnancy female;\n4. Subject understands study requirements and agrees to sign an informed consent from prior to study procedures.\n\nExclusion Criteria:\n\n1. Pregnancy female;\n2. Participate in other clinical trial in the last 1 month.\n3. Subject doesn't agree to sign an informed consent from prior to study procedures.\n4. Subject undergoing repeat CABG, concomitant valve or other cardiac surgery.\n5. New York Heart Association (NYHA) Class IV heart failure.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Yulin Li, PHD","role":"CONTACT","phone":"86-010-64426153","email":"lyllyl_1111@163.com"},{"name":"Ping Li, PHD","role":"CONTACT","email":"13520112185@163.com"}],"overallOfficials":[{"name":"Ping Li, PHD","affiliation":"Beijing Anzhen Hospital","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Beijing Anzhen Hospital","status":"RECRUITING","city":"Beijing","zip":"100029","country":"China","contacts":[{"name":"ke-xu Yang","role":"CONTACT","phone":"86-010-64426153","email":"EC@anzhenGCP.com"}],"geoPoint":{"lat":39.9075,"lon":116.39723}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"}]}},"hasResults":false}